Clinical Informatics News May 15, 2019
Between 1995 and 2015, pharmaceutical R&D spending nearly quadrupled, while the rate of FDA-approved drugs has stayed roughly the same (Pharmaceutical Market Europe). To compound the issue, R&D returns have diminished by nearly 7% between 2010 and 2017 (Deloitte). In other words, sponsors are spending more to get the same results. And the cause? Oftentimes, poor trial design.
Digital Health is emerging as a solution to these challenges. By incorporating technologies such as AI, big data, wearables, sensors, and smartphone apps, Digital Health has the potential to improve trial design from start-up to close-out, increase R&D productivity, and provide the data that sponsors need for better decision-making.
Pulling Clinical Trials Into The Digital World
Many challenges have arisen from traditional...
Today's Sponsors
Today's Sponsor